Bandaríkin - enska - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - fluconazole (unii: 8vzv102jfy) (fluconazole - unii:8vzv102jfy) - fluconazole tablets usp are indicated for the treatment of: fluconazole tablets usp are also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy. specimens for fungal culture and other relevant laboratory studies (serology, histopathology) should be obtained prior to therapy to isolate and identify causative organisms. therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly. fluconazole is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients. there is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. caution should be used in prescribing fluconazole to patients with hypersensitivity to other azoles. coadministration of terfenadine is contraindicated in patie

Bandaríkin - enska - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - fluconazole (unii: 8vzv102jfy) (fluconazole - unii:8vzv102jfy) - fluconazole tablets are indicated for the treatment of: prophylaxis: fluconazole tablets are also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy. specimens for fungal culture and other relevant laboratory studies (serology, histopathology) should be obtained prior to therapy to isolate and identify causative organisms. therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly. fluconazole is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients. there is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. caution should be used in prescribing fluconazole to patients with hypersensitivity to other azoles. coadministration of terfenadine is contraindicated in

Írland - enska - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - clarithromycin; clarithromycin - powder for concentrate for solution for infusion - 500 milligram(s) - macrolides; clarithromycin

Írland - enska - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - clarithromycin - pdr/conc/soln for infus - 500 milligram(s) - macrolides; clarithromycin

Írland - enska - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - clarithromycin - film coated tablet - 250 milligram - macrolides

Írland - enska - HPRA (Health Products Regulatory Authority)

accord healthcare limited - clarithromycin - film coated tablet - 250 milligram - clarithromycin

Írland - enska - HPRA (Health Products Regulatory Authority)

accord healthcare limited - clarithromycin - film coated tablet - 500 milligram - clarithromycin

Evrópusambandið - enska - EMA (European Medicines Agency)

roche registration ltd. - nelfinavir - hiv infections - antivirals for systemic use - viracept is indicated in antiretroviral combination treatment of human-immunodeficiency-virus (hiv-1)-infected adults, adolescents and children of three years of age and older.in protease-inhibitor (pi)-experienced patients, the choice of nelfinavir should be based on individual viral resistance testing and treatment history.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - fluconazole - oral capsule - 150mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - clarithromycin - modified-release tablet - 500mg